During the past decade, Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Universidade do Porto" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Centro Hospitalar de Entre o Douro e Vouga" with 1 trials as a collaborator, "Centro Hospitalar de Vila Nova de Gaia/Espinho" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" are "Pain, Postoperative" (2 trials), "Ulcerative Colitis" (2 trials), "Alzheimer Disease" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" are "Drug" (15 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gemcitabine" (2 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".